Type I-Polarized Autologous Dendritic Cell Vaccine (University of Pittsburgh)

I型极化自体树突状细胞疫苗（匹兹堡大学）

Report date: 2025/05/15 20:00:08

Base Information

Drug NameType I-Polarized Autologous Dendritic Cell Vaccine (University of Pittsburgh)
Drug Alias Namealpha DC1 cellsAlpha-type-1 polarized dendritic cellsAlpha-type-1 polarized dendritic cell vaccine
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSkin MelanomaUterine Cervical NeoplasmsFallopian Tube Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoswell Park Cancer InstituteUniversity Of PittsburghNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsSkin MelanomaUterine Cervical NeoplasmsFallopian Tube Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksN/A